San Marcos, CA, United States of America

David C Griffith

USPTO Granted Patents = 35 

 

 

Average Co-Inventor Count = 5.1

ph-index = 10

Forward Citations = 279(Granted Patents)


Location History:

  • San Marcose, CA (US) (2016)
  • San Marcos, CA (US) (2010 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
35 patents (USPTO):

Title: David C. Griffith: Innovator in Antimicrobial and Pharmaceutical Compositions

Introduction

David C. Griffith is a prominent inventor based in San Marcos, California, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 34 patents, he has dedicated his career to advancing therapeutic agents, particularly in antimicrobial and tetracycline compositions.

Latest Patents

Among his latest innovations are two noteworthy patents. The first patent focuses on "Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives." This patent discloses antimicrobial compounds, compositions, and their therapeutic applications. The second patent is centered on "Tetracycline compositions," which details pharmaceutical preparations boasting improved stability and solubility, featuring a tetracycline combined with excess divalent or trivalent cations.

Career Highlights

David has notably worked with reputable companies, including Rempex Pharmaceuticals and Horizon Orphan LLC. His work at these organizations has paved the way for significant advancements in pharmaceutical compositions, allowing for the development of more effective therapeutic agents.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Michael N. Dudley and Olga Rodny. These collaborations highlight the importance of teamwork in pushing the boundaries of innovation within the pharmaceutical landscape.

Conclusion

David C. Griffith's dedication to pharmaceutical innovations exemplifies the impact of inventors in improving healthcare solutions. With his substantial portfolio of patents and collaborations with leading professionals, he continues to make strides in the development of effective antimicrobial treatments and compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…